Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.45 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.37 |
| ▸ | TNF | P01375 | 1/20 | 0.36 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.36 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.36 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4385060 | 0.91 | CYP1A2 (0.46) | CYP4F2CYP4A11MAPTCYP1A2CYP3A4 | |
| SCHEMBL7420112 | 0.86 | LTA4H (0.42) | CYP4F2CYP4A11MAPTALDH1A1 | |
| SCHEMBL11296881 | 0.84 | CTDSP1 (0.38) | MAPTLMNAALDH1A1KDM4EHSD17B10 | |
| SCHEMBL9555487 | 0.83 | LTA4H (0.46) | CYP4F2CYP4A11MAPTCYP1A2CYP3A4 | |
| SCHEMBL1039137 | 0.83 | TSHR (0.40) | MAPTLMNAALDH1A1KDM4EHSD17B10 | |
| SCHEMBL1441637 | 0.83 | KMT2A (0.44) | LMNAALDH1A1KDM4EHSD17B10CYP2C9 | |
| Hydrochloric Acid SCHEMBL1039136 | 0.82 | TSHR (0.39) | MAPTLMNAALDH1A1KDM4EHSD17B10 | |
| SCHEMBL18381220 | 0.81 | CYP3A4 (0.45) | MAPTALDH1A1KDM4EHSD17B10L3MBTL1 | |
| SCHEMBL9642033 | 0.81 | TSHR (0.41) | MAPTALDH1A1KDM4EHSD17B10L3MBTL1 | |
| Hydrochloric Acid SCHEMBL9547309 | 0.79 | DGAT1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10475593-B2 | Use of halogen derivatives of histidine as electrolytic salt in a photovoltaic dye cell | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2019-11-12 | — | — | US | disclosed |
| US-10475593-B2 | Use of halogen derivatives of histidine as electrolytic salt in a photovoltaic dye cell | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2019-11-12 | — | — | US | disclosed |
| EP-3215494-B1 | USE OF HALOGEN DERIVATIVES OF HISTIDINE AS ELECTROLYTIC SALT IN A PHOTOVOLTAIC DYE CELL | CENTRE NAT RECH SCIENT (FR) | 2018-12-12 | — | — | EP | disclosed |
| US-20170323732-A1 | USE OF HALOGEN DERIVATIVES OF HISTIDINE AS ELECTROLYTIC SALT IN A PHOTOVOLTAIC DYE CELL | UNIVERSITE DE PICARDIE JULES VERNE (FR) | 2017-11-09 | — | — | US | disclosed |
| US-20170323732-A1 | USE OF HALOGEN DERIVATIVES OF HISTIDINE AS ELECTROLYTIC SALT IN A PHOTOVOLTAIC DYE CELL | UNIVERSITE DE PICARDIE JULES VERNE (FR) | 2017-11-09 | — | — | US | disclosed |
| US-20170323732-A1 | USE OF HALOGEN DERIVATIVES OF HISTIDINE AS ELECTROLYTIC SALT IN A PHOTOVOLTAIC DYE CELL | UNIVERSITE DE PICARDIE JULES VERNE (FR) | 2017-11-09 | — | — | US | disclosed |
| EP-3215494-A1 | USE OF HALOGEN DERIVATIVES OF HISTIDINE AS ELECTROLYTIC SALT IN A PHOTOVOLTAIC DYE CELL | Centre National De La Recherche Scientifique (FR) | 2017-09-13 | — | — | EP | disclosed |
| WO-2016071637-A1 | USE OF HALOGEN DERIVATIVES OF HISTIDINE AS ELECTROLYTIC SALT IN A PHOTOVOLTAIC DYE CELL | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-05-12 | — | — | WO | disclosed |
| WO-2016071637-A1 | USE OF HALOGEN DERIVATIVES OF HISTIDINE AS ELECTROLYTIC SALT IN A PHOTOVOLTAIC DYE CELL | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-05-12 | — | — | WO | disclosed |
| US-5856326-A | ANTITUMOR, ANTICANCER AGENTS | MERCK & CO., INC. (US) | 1999-01-05 | — | — | US | disclosed |
| CN-1195340-A | Inhibitors of farnesyl-protein transferase | MERCK & CO INC (US) | 1998-10-07 | — | — | CN | disclosed |
| EP-0820445-A1 | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | Merck & Co., Inc. (US) | 1998-01-28 | — | — | EP | disclosed |
| WO-1996030343-A1 | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 1996-10-03 | — | — | WO | disclosed |
| US-4652519-A | Bifunctional chelating agents and process for their production | YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) | 1987-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170323732-A1 | USE OF HALOGEN DERIVATIVES OF HISTIDINE AS ELECTROLYTIC SALT IN A PHOTOVOLTAIC DYE CELL | HDHD5, HCLS1, HCN1 | CYP4F2 1820/4885CYP4A11 3801/4885MAPT 2670/4885 |
| US-10475593-B2 | Use of halogen derivatives of histidine as electrolytic salt in a photovoltaic dye cell | HDHD5, HCLS1, HCN1 | CYP4F2 1820/4885CYP4A11 3801/4885MAPT 2670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.